These are usually mild to moderate and typically appear when treatment starts or the dose is increased
Long-Term Safety Monitoring Results Clinical trials lasting 6 to 12 months may never detect ADA formation, which develops over extended use
This can lead to infections like HIV, hepatitis, and various bacterial infections, which can have serious or even fatal consequences
5.5 Acute Kidney Injury Due to Volume Depletion There have been postmarketing reports of acute kidney injury, in some cases requiring hemodialysis, in patients treated with semaglutide
Storage Instructions Store mixed semaglutide in a refrigerator (28C or 3646F) Do not freeze Use within 28 days of reconstitution Always use sterile syringes for each dose withdrawal Properly mixing semaglutide with bacteriostatic water ensures both safety and efficacy

Ingredients List: AQUAGLYCERINPROPYLENE GLYCOLISOPROPYL MYRISTATENIACINAMIDEDIMETHICONECETEARYL ALCOHOLGLYCERYL STEARATEASCORBIC ACID POLYPEPTIDEPEG-100 STEARATEPHENOXYETHANOL3-O-ETHYL ASCORBIC ACIDARBUTINTRIETHANOLAMINECARBOMERPOLYACRYLAMIDEHYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMERC13-14 ISOPARAFFINACETYL TYROSINECETEARYL GLUCOSIDEALOE BARBADENSIS LEAF EXTRACTETHYLHEXYLGLYCERINDISODIUM EDTATOCOPHERYL ACETATEGLYCYRRHIZA URALENSIS (LICORICE) ROOT EXTRACTACETYL CYSTEINEALANINECITRUS AURANTIUM DULCIS (ORANGE) PEEL OILLAURETH-7BUTYLENE GLYCOLSORBITAN ISOSTEARATEPOLYSORBATE 60HYDROXYACETOPHENONETREMELLA FUCIFORMIS SPOROCARP EXTRACTSODIUM HYALURONATE1,2-HEXANEDIOLBETA-GLUCANDIPOTASSIUM GLYCYRRHIZATEGLUTATHIONECI 19140CI 14700